These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 19643666)

  • 21. Chronic rhinosinusitis with polyps and without polyps is associated with increased expression of suppressors of cytokine signaling 1 and 3.
    Park SJ; Kim TH; Jun YJ; Lee SH; Ryu HY; Jung KJ; Jung JY; Hwang GH; Lee SH
    J Allergy Clin Immunol; 2013 Mar; 131(3):772-80. PubMed ID: 23375208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-10 anti-inflammatory response to Borrelia burgdorferi, the agent of Lyme disease: a possible role for suppressors of cytokine signaling 1 and 3.
    Dennis VA; Jefferson A; Singh SR; Ganapamo F; Philipp MT
    Infect Immun; 2006 Oct; 74(10):5780-9. PubMed ID: 16988256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and validation of SOCS1/2/3/4 as potential prognostic biomarkers and correlate with immune infiltration in glioblastoma.
    Dai L; Han Y; Yang Z; Zeng Y; Liang W; Shi Z; Tao Y; Liang X; Liu W; Zhou S; Xing Z; Hu W; Wang X
    J Cell Mol Med; 2023 Aug; 27(15):2194-2214. PubMed ID: 37315184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
    Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
    J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended anti-inflammatory action of a degradation-resistant mutant of cell-penetrating suppressor of cytokine signaling 3.
    Fletcher TC; DiGiandomenico A; Hawiger J
    J Biol Chem; 2010 Jun; 285(24):18727-36. PubMed ID: 20400504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities.
    Song MM; Shuai K
    J Biol Chem; 1998 Dec; 273(52):35056-62. PubMed ID: 9857039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling.
    Ben-Zvi T; Yayon A; Gertler A; Monsonego-Ornan E
    J Cell Sci; 2006 Jan; 119(Pt 2):380-7. PubMed ID: 16410555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance.
    Egwuagu CE; Yu CR; Zhang M; Mahdi RM; Kim SJ; Gery I
    J Immunol; 2002 Apr; 168(7):3181-7. PubMed ID: 11907070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of interferon α and β, pro-inflammatory cytokines and the expression of suppressor of cytokine signaling (SOCS) in obese subjects infected with influenza A/H1N1.
    Terán-Cabanillas E; Montalvo-Corral M; Silva-Campa E; Caire-Juvera G; Moya-Camarena SY; Hernández J
    Clin Nutr; 2014 Oct; 33(5):922-6. PubMed ID: 24182768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusion protein of tapasin and hepatitis B core antigen 18‑27 enhances T helper cell type 1/2 cytokine ratio and antiviral immunity by inhibiting suppressors of cytokine signaling family members 1/3 in hepatitis B virus transgenic mice.
    Tang Y; Chen X; Zhang Y; Tang Z; Zhuo M; Li D; Wang P; Zang G; Yu Y
    Mol Med Rep; 2014 Apr; 9(4):1171-8. PubMed ID: 24535102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOCS proteins: negative regulators of cytokine signaling.
    Krebs DL; Hilton DJ
    Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the role of SOCS signaling in neurodegenerative diseases: Current and emerging concepts.
    Cianciulli A; Calvello R; Porro C; Trotta T; Panaro MA
    Cytokine Growth Factor Rev; 2017 Oct; 37():67-79. PubMed ID: 28801024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
    Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3.
    Tamiya T; Kashiwagi I; Takahashi R; Yasukawa H; Yoshimura A
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):980-5. PubMed ID: 21508344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins.
    Dimitriou ID; Clemenza L; Scotter AJ; Chen G; Guerra FM; Rottapel R
    Immunol Rev; 2008 Aug; 224():265-83. PubMed ID: 18759933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of SOCS is altered in rheumatoid arthritis.
    Isomäki P; Alanärä T; Isohanni P; Lagerstedt A; Korpela M; Moilanen T; Visakorpi T; Silvennoinen O
    Rheumatology (Oxford); 2007 Oct; 46(10):1538-46. PubMed ID: 17726036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins.
    Zimmerer JM; Lesinski GB; Kondadasula SV; Karpa VI; Lehman A; Raychaudhury A; Becknell B; Carson WE
    J Immunol; 2007 Apr; 178(8):4832-45. PubMed ID: 17404264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of SOCS Expression by EV71 Infection Promotes EV71 Replication.
    Gao W; Hou M; Liu X; Li Z; Yang Y; Zhang W
    Biomed Res Int; 2020; 2020():2430640. PubMed ID: 32149091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.
    Sedeño-Monge V; Arcega-Revilla R; Rojas-Morales E; Santos-López G; Perez-García JC; Sosa-Jurado F; Vallejo-Ruiz V; Solis-Morales CL; Aguilar-Rosas S; Reyes-Leyva J
    J Neuroimmunol; 2014 Aug; 273(1-2):117-9. PubMed ID: 24951315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformation.
    Cooper JC; Shi M; Chueh FY; Venkitachalam S; Yu CL
    Int J Oncol; 2010 May; 36(5):1201-8. PubMed ID: 20372794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.